The immunogenic potential of antigens generated through PDT-induced ICD is not merely a consequence of DAMP release but also the qualitative changes in the antigenic peptides presented by major histocompatibility complex (MHC) molecules on the surface of dying tumor cells. The gene discussed is HLA-C; the disease is neoplasm.